137 related articles for article (PubMed ID: 21469214)
1. Could thiazolidinediones increase the risk of heart failure in Friedreich's ataxia patients?
García-Giménez JL; Sanchis-Gomar F; Pallardó FV
Mov Disord; 2011 Apr; 26(5):769-71. PubMed ID: 21469214
[TBL] [Abstract][Full Text] [Related]
2. Friedreich's ataxia cardiomyopathy: case based discussion and management issues.
Hanley A; Corrigan R; Mohammad S; MacMahon B
Ir Med J; 2010 Apr; 103(4):117-8. PubMed ID: 20486316
[TBL] [Abstract][Full Text] [Related]
3. Potential for peroxisome proliferator-activated receptor-gamma agonists in progression: beyond metabolism.
Fogo AB
Curr Opin Nephrol Hypertens; 2008 May; 17(3):282-5. PubMed ID: 18408479
[TBL] [Abstract][Full Text] [Related]
4. The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality.
Stafylas PC; Sarafidis PA; Lasaridis AN
Int J Cardiol; 2009 Jan; 131(3):298-304. PubMed ID: 18684530
[TBL] [Abstract][Full Text] [Related]
5. Rationale for clinical trials of selenium as an antioxidant for the treatment of the cardiomyopathy of Friedreich's ataxia.
Fryer MJ
Med Hypotheses; 2002 Feb; 58(2):127-32. PubMed ID: 11812188
[TBL] [Abstract][Full Text] [Related]
6. [Two case studies of hypertrophic cardiomyopathy in Friedreich's ataxia].
Cervantes-Arriaga A; Rodríguez-Violante M; Villar-Velarde A; Vargas-Cañas S
Gac Med Mex; 2009; 145(4):343-6. PubMed ID: 20073435
[TBL] [Abstract][Full Text] [Related]
7. Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia.
Bunse M; Bit-Avragim N; Riefflin A; Perrot A; Schmidt O; Kreuz FR; Dietz R; Jung WI; Osterziel KJ
Ann Neurol; 2003 Jan; 53(1):121-3. PubMed ID: 12509856
[TBL] [Abstract][Full Text] [Related]
8. [Cardiac involvement in Friedreich's heredo-ataxia].
Bertoni PD; Canziani R; Cozzi G; Arancio F; Marforio S
G Ital Cardiol; 1986 Jan; 16(1):22-9. PubMed ID: 2940141
[TBL] [Abstract][Full Text] [Related]
9. PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy.
Marmolino D; Acquaviva F; Pinelli M; Monticelli A; Castaldo I; Filla A; Cocozza S
Cerebellum; 2009 Jun; 8(2):98-103. PubMed ID: 19104905
[TBL] [Abstract][Full Text] [Related]
10. Cardiac pharmacology and cardiomyopathy in Friedreich's ataxia.
Huxtable RJ
Can J Neurol Sci; 1978 Feb; 5(1):83-91. PubMed ID: 25706
[TBL] [Abstract][Full Text] [Related]
11. Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism.
Pan HJ; Lin Y; Chen YE; Vance DE; Leiter EH
Vascul Pharmacol; 2006 Jul; 45(1):65-71. PubMed ID: 16750656
[TBL] [Abstract][Full Text] [Related]
12. Friedreich's ataxia: clinical aspects and pathogenesis.
Pandolfo M
Semin Neurol; 1999; 19(3):311-21. PubMed ID: 12194387
[TBL] [Abstract][Full Text] [Related]
13. [Cardiac manifestations of Friedreich's ataxia].
Kolek M; Mrózek V; Schenk P
Cas Lek Cesk; 2004; 143(1):48-51. PubMed ID: 15061120
[TBL] [Abstract][Full Text] [Related]
14. Cardiac transplantation: a temporary solution for Friedreich's ataxia-induced dilated cardiomyopathy.
Sedlak TL; Chandavimol M; Straatman L
J Heart Lung Transplant; 2004 Nov; 23(11):1304-6. PubMed ID: 15539131
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factors.
Schernthaner G
Int J Clin Pract; 2009 Jun; 63(6):912-29. PubMed ID: 19490202
[TBL] [Abstract][Full Text] [Related]
16. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
17. Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure.
Erdmann E; Wilcox RG
Eur Heart J; 2008 Jan; 29(1):12-20. PubMed ID: 18167366
[TBL] [Abstract][Full Text] [Related]
18. Septal myectomy for hypertrophic obstructive cardiomyopathy in Friedreich's ataxia.
Anderson HN; Burkhart HM; Johnson JN
Cardiol Young; 2016 Jan; 26(1):175-8. PubMed ID: 25687499
[TBL] [Abstract][Full Text] [Related]
19. [Heart involvement in Friedreich's ataxia].
Weidemann F; Scholz F; Florescu C; Liu D; Hu K; Herrmann S; Ertl G; Störk S
Herz; 2015 Mar; 40 Suppl 1():85-90. PubMed ID: 24848865
[TBL] [Abstract][Full Text] [Related]
20. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.
Panunti B; Fonseca V
Vascul Pharmacol; 2006 Jul; 45(1):29-35. PubMed ID: 16777491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
